Text Size: A+| A-| A   |   Text Only Site   |   Accessibility

    Kevin Willingham   
503-934-6014   

Medical quality initiative -
what we've accomplished / past projects

MQI - Pharmacy Project

The WCD Executive Team chartered the MQI Pharmacy Project in July 2006. The project team worked closely with key stakeholders, surveyed workers' compensation (WC) payers, researched pharmacy literature, completed data analyses, and prepared recommendations relating to pharmaceutical cost controls to the WCD Executive Team in January 2007. The Executive Summary and related attachments are found in the links below:

Executive Summary
Project charter
Definitions and glossary
Data Analyses
Drug Effectiveness Review Project (DERP)
Follow the Pill - U.S. Commercial Pharmaceutical Supply Chain
Health Strategy - Payer Prescription Drug Management Survey
Heinz Report - The Oregon Blueprint
Kaiser Foundation Drug Trends
Oregon Payer Survey
NCCI Prescription Drug Study- 2004
NCCI Prescription Drug Study- 2006 Update
Pharmacy Fee Advisory Task Force 2003
WCRI 2006 Pharmaceuticals Guide for Policymakers

 
Treatment and Guidelines Committee
The Treatment and Guidelines Committee explored the development or adoption of treatment guidelines, development of a training and voluntary certification program for medical providers, and reduction and simplification of paperwork for medical providers. After receiving input from stakeholders throughout the state, the Committee presented its final report to the WCD Executive Committee in March 2006. The report stated that there was minimal interest in adopting treatment guidelines and certifying medical providers. Although many stakeholders were concerned about "outliers", there was no consensus on how to address "outliers". Stakeholders, however, did support the concept of training medical providers and their staff in the principles of workers' compensation, return-to-work, and technical areas of reporting and billing.

Treatment & Guidelines Full Report
Treatment & Guidelines Stakeholder Meeting Notes

 
MQI - Reporting Evaluation Phase (REP)
The MQI-REP Committee reviewed statute and rule requirements, assessed WCD and the Department of Consumer and Business Services (DCBS) needs for and uses of data obtained, and interviewed providers and industry representatives. In addition, the Committee reviewed and analyzed significant background factors, including recommendations from the Paperwork Reduction Taskforce, the impact of the major contributing cause standard, and the development of electronic data interchange. The Committee presented its final report to the WCD Executive Committee in June 2006.

MQI-REP Full Report

Based on the recommendations from the MQI Committees, the Executive Team approved the following projects:

MQI - Pharmacy
MQI - EDI (Electronic Data Interchange)

MQI - Provider Outreach

 
 


Home
Current projects - What we're working on
Data Analysis
If you have questions about this Web page, please contact Kevin Willingham, 503-934-6014.

 

Get Adobe Acrobat ReaderAdobe Reader is required to view PDF files. Click the "Get Adobe Reader" image to get a free download of the reader from Adobe. Available for Macintosh or Windows.